Dietary Peanuts and Nutrition-Related Outcomes

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorIan J. Neeland, MD

About this trial

This study will look at how eating peanuts every day might affect participants weight, how healthy their diet is, and how they feel when eating. Investigators want to see if adding peanuts to meals for 12 weeks helps participants feel fuller, have more energy, and improve body composition. The study will include adults who have been taking GLP-1 medicines like semaglutide or tirzepatide for at least three months. Investigators also want to see if eating peanuts improves overall diet quality and health markers like tiredness and certain levels in blood.

Eligibility criteria

Qualifiers

Individuals with a BMI ≥30 kg/m2 or with a BMI ≥27 kg/m2 with at least one weight-related comorbidity who have been using semaglutide or tirzepatide for a clinical indication or at least 6 months

Disqualifiers

No use or contraindication to use of a GLP-1 RA

Known allergy to nuts

Pregnant or breastfeeding

Incarcerated

Trial design

Treatments tested in this trial

  • Peanuts
  • Dual-energy X-ray absorptiometry (DEXA) scans

Treatment groups

64 Participants
are divided into 2 treatment groups

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

University Hospitals Cleveland Medical CenterRecruiting44106, Clevland, OhioUnited StatesUnited States

Sponsors and collaborators

Ian J. Neeland, MD

Lead sponsor

University Hospitals Cleveland Medical Center

Sponsor institution